Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans

Table 1

Demographic and clinic characteristics of groups before the treatment*.

Parameters	UDCA; (𝑛=22)	UDCA and domperidone (𝑛=18)	Control (𝑛=13)
Mean age	45.4±12	42.7±13	49.0±8
Gender (F/M)	18/4	16/2	11/2
BMI (kg/m^2)	29.0±4	27.1±3	30.3±5
Glucose (mg/dL)	90.5±11	99.1±20	96.2±7
Cholesterol (mg/dL)	182.4±34	186.1±30	177.0±26
HDL-cholesterol (mg/dL)	49.7±16	53.5±17	43.0±9
LDL-cholesterol (mg/dL)	105.0±35	104.3±51	108.4±15
Triglyceride (mg/dL)	136.5±75	157.4±90	145.7±81
Solitary stone	6	4	2
Diameters of solitary stones (mm)	8.1±3.1	8.2±3.3	8±3.6
Multiple stone	16	14	11
FGVav (mL)	26.6±9.6	27.8±13.4	25.4±6.2
RGVav (mL)	7.0±3	7.8±5	6.3±6
EFav (%)	73.6±15	71.9±19	75.1±18

*Results are expressed as mean ± SD.
BMI: body mass index; FGV_av: average fasting gallbladder volume; RGV_av: average residual gallbladder volume; EF_av: average ejection fraction.